Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer

被引:6
作者
Altundag, K
Altundag, O
Atik, MA
Morandi, P
Gunduz, M
机构
[1] Hacettepe Univ, Dept Med Oncol, Fac Med, Ankara, Turkey
[2] Baylor Coll Med, Dept Pulm & Crit Care Med, Houston, TX 77030 USA
[3] S Bortolo Gen Hosp, Dept Med Oncol, Vicenza, Italy
[4] Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med & Dent, Okayama, Japan
关键词
D O I
10.1016/j.breast.2004.08.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:425 / 425
页数:1
相关论文
共 8 条
[1]   Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab [J].
Baculi, RH ;
Suki, S ;
Nisbett, J ;
Leeds, N ;
Groves, M .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3297-3298
[2]   Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma [J].
Bendell, JC ;
Domchek, SM ;
Burstein, HJ ;
Harris, L ;
Younger, J ;
Kuter, I ;
Bunnell, C ;
Rue, M ;
Gelman, R ;
Winer, E .
CANCER, 2003, 97 (12) :2972-2977
[3]   Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer [J].
Clayton, AJ ;
Danson, S ;
Jolly, S ;
Ryder, WDJ ;
Burt, PA ;
Stewart, AL ;
Wilkinson, PM ;
Welch, RS ;
Magee, B ;
Wilson, G ;
Howell, A ;
Wardley, AM .
BRITISH JOURNAL OF CANCER, 2004, 91 (04) :639-643
[4]   Chemotherapy for breast cancer brain metastases [J].
Fenner, MH ;
Possinger, K .
ONKOLOGIE, 2002, 25 (05) :474-479
[5]   HER2 in brain metastases:: issues of concordance, survival, and treatment [J].
Fuchs, IB ;
Loebbecke, M ;
Buhler, H ;
Stoltenburg-Didinger, G ;
Heine, B ;
Lichtenegger, W ;
Schaller, G .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) :4130-4133
[6]  
Liang K, 2003, MOL CANCER THER, V2, P1113
[7]   The role of chemotherapy in brain metastases [J].
van den Bent, MJ .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (15) :2114-2120
[8]  
van Vulpen M, 2002, ONCOL REP, V9, P683